Experienced MedTech Executive to Lead Axena Health as it Leverages its Clinical Evidence and Commercial Growth to Improve the Standard of Care in Female Pelvic Health
Axena Health, Inc. (Axena Health), a medical device company focused on female pelvic health, today announced the appointment of Randy Pritchard as its new Chief Executive Officer, effective immediately. Pritchard brings nearly 25 years of experience in medical device and health technology, including leadership in driving commercial success, innovation, and strategic opportunities. His extensive background will be critical in advancing Axena Health’s mission to improve the lives of women affected by pelvic floor disorders such as urinary incontinence (UI) and fecal incontinence (FI).
Pritchard joins Axena Health with a proven track record in strategic leadership and business expansion. He most recently served as CEO of Pillar Biosciences, a sequencing diagnostics company supporting cancer patients, where he led daily operations, secured funding, and drove top and bottom-line performance. Pritchard’s prior leadership at Roche Diagnostics, where he held key roles as Senior Vice President of Marketing, further highlights his ability to launch disruptive new technologies and implement strategies that boost customer satisfaction and increase sales.
As CEO of Axena Health, Pritchard will oversee the company’s operations and growth strategy, focusing on expanding access to the company’s flagship product, the Leva® Pelvic Health System. The Leva System offers a non-invasive, medication-free solution for treating UI and FI, addressing critical gaps in the women’s health space. Under Pritchard’s leadership, Axena Health will continue building partnerships, raising capital to support growth, and executing on its vision to provide evidence-based, at-home, first-line treatments for female pelvic floor disorders.
Shacey Petrovic, Board Member at Axena Health, added: “Randy has a strong history of leading innovative companies and delivering meaningful healthcare solutions. His proven ability to execute growth strategies and build a mission-driven culture aligns perfectly with Axena Health’s vision of changing the standard of care for female pelvic floor disorders.”
“We are excited to have Randy Pritchard leading Axena Health into its next phase of growth,” said Bret Christensen, Chairman of the Board at Axena Health. “Randy’s commercial acumen, operational expertise, and passion for improving patient outcomes make him the ideal leader to take Axena Health forward as we broaden access to its transformative pelvic health treatments for women.”
In his new role, Pritchard will focus on refining the company’s strategic direction, improving insurance coverage for the Leva System, and driving operations across all functional areas, including sales and marketing and market access. He will also lead efforts to expand strategic partnerships within the women’s health space, while continuing to position the Leva System as the only prescription, at-home, first-line treatment for female UI and FI.
“I am thrilled to join Axena Health at this pivotal time,” said Randy Pritchard. “The company’s mission to transform women’s health with innovative, non-invasive treatments deeply resonates with me. I look forward to working with the company’s talented team to scale the business, continue product innovation, and improve access to effective solutions for pelvic floor disorders.”
Explore AITechPark for the latest advancements in AI, IOT, Cybersecurity, AITech News, and insightful updates from industry experts!
